Profiel
Lisa Amaya Price is currently Chief Human Resources Officer at Disc Medicine, Inc. since 2026.
Formerly, Ms. Price was Chief Human Resources Officer & Senior VP at Deciphera Pharmaceuticals, Inc. from 2022 to 2026 and Chief People Officer at LGC Group, Inc. Education includes graduate studies at Simmons University, undergraduate studies at Bard College, and an MBA from F.W.
Olin Graduate School of Business.
Actieve functies van Lisa Amaya Price
| Bedrijven | Functie | Begin |
|---|---|---|
| DISC MEDICINE, INC. | Human Resources Officer | 12-01-2026 |
Eerdere bekende functies van Lisa Amaya Price
| Bedrijven | Functie | Einde |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Human Resources Officer | 01-01-2026 |
LGC Group, Inc.
LGC Group, Inc. Medical SpecialtiesHealth Technology Develops life science tools, components and solutions | Human Resources Officer | - |
Opleiding van Lisa Amaya Price
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Simmons University
Simmons University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bard College
Bard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F.W. Olin Graduate School of Business
F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
LGC Group, Inc.
LGC Group, Inc. Medical SpecialtiesHealth Technology Develops life science tools, components and solutions | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
















